Susrutha Puthanmadhom Narayanan1, Daniel R O'Brien2, Mayank Sharma1, Thomas C Smyrk3, Rondell P Graham3, Madhusudan Grover1, Adil E Bharucha4. 1. Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota. 2. Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota. 3. Division of Anatomic Pathology, Mayo Clinic, Rochester, Minnesota. 4. Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota. Electronic address: scipubs@mayo.edu.
Abstract
BACKGROUND & AIMS: In addition to gastric sensorimotor dysfunctions, functional dyspepsia (FD) is also variably associated with duodenal micro-inflammation and epithelial barrier dysfunction, the pathogenesis and clinical significance of which are unknown. Our hypothesis was that miRNAs and/or inflammation degrade epithelial barrier proteins, resulting in increased duodenal mucosal permeability in FD. METHODS: We compared the duodenal mucosal gene expression and miRNAs, in vivo permeability (lactulose-mannitol excretion between 0 and 60 and 60 and 120 minutes after saccharide ingestion), ex vivo assessments (transmucosal resistance, fluorescein isothiocyanate [FITC]-dextran flux, and basal ion transport), and duodenal histology (light and electron microscopy) in 40 patients with FD and 24 controls. RESULTS: Compared with controls, the mRNA expression of several barrier proteins (zonula occludens-1, occludin, claudin-12, and E-cadherin) was modestly reduced (ie, a fold change of 0.8-0.85) in FD with increased expression of several miRNAs (eg, miR-142-3p and miR-144-3-p), which suppress these genes. The urinary lactulose excretion and the lactulose:mannitol ratio between 60 and 120 minutes were greater in FD than in controls (P < .05). The FITC-dextran flux, which reflects paracellular permeability, was inversely correlated (r = -0.32, P = .03) with transmucosal resistance and directly correlated (r = 0.4, P = .02) with lactulose:mannitol ratio. Other parameters (mucosal eosinophils, intraepithelial lymphocytes, and mast cells, transmucosal resistance, FITC-dextran flux, average intercellular distance, and proportion of dilated junctions) were not significantly different between groups. CONCLUSIONS: In FD, there is a modest reduction in the expression of several duodenal epithelial barrier proteins, which may be secondary to up-regulation of regulatory miRNAs, and increased small intestinal permeability measured in vivo.
BACKGROUND & AIMS: In addition to gastric sensorimotor dysfunctions, functional dyspepsia (FD) is also variably associated with duodenal micro-inflammation and epithelial barrier dysfunction, the pathogenesis and clinical significance of which are unknown. Our hypothesis was that miRNAs and/or inflammation degrade epithelial barrier proteins, resulting in increased duodenal mucosal permeability in FD. METHODS: We compared the duodenal mucosal gene expression and miRNAs, in vivo permeability (lactulose-mannitol excretion between 0 and 60 and 60 and 120 minutes after saccharide ingestion), ex vivo assessments (transmucosal resistance, fluorescein isothiocyanate [FITC]-dextran flux, and basal ion transport), and duodenal histology (light and electron microscopy) in 40 patients with FD and 24 controls. RESULTS: Compared with controls, the mRNA expression of several barrier proteins (zonula occludens-1, occludin, claudin-12, and E-cadherin) was modestly reduced (ie, a fold change of 0.8-0.85) in FD with increased expression of several miRNAs (eg, miR-142-3p and miR-144-3-p), which suppress these genes. The urinary lactulose excretion and the lactulose:mannitol ratio between 60 and 120 minutes were greater in FD than in controls (P < .05). The FITC-dextran flux, which reflects paracellular permeability, was inversely correlated (r = -0.32, P = .03) with transmucosal resistance and directly correlated (r = 0.4, P = .02) with lactulose:mannitol ratio. Other parameters (mucosal eosinophils, intraepithelial lymphocytes, and mast cells, transmucosal resistance, FITC-dextran flux, average intercellular distance, and proportion of dilated junctions) were not significantly different between groups. CONCLUSIONS: In FD, there is a modest reduction in the expression of several duodenal epithelial barrier proteins, which may be secondary to up-regulation of regulatory miRNAs, and increased small intestinal permeability measured in vivo.
Authors: Subhankar Chakraborty; Anshuman Desai; Magnus Halland; Duane Burton; Michael Camilleri; Alan R Zinsmeister; Adil E Bharucha Journal: Neurogastroenterol Motil Date: 2019-07-21 Impact factor: 3.598
Authors: Nicholas J Talley; Marjorie M Walker; Pertti Aro; Jukka Ronkainen; Tom Storskrubb; Laura A Hindley; W Scott Harmsen; Alan R Zinsmeister; Lars Agréus Journal: Clin Gastroenterol Hepatol Date: 2007-08-07 Impact factor: 11.382
Authors: Marc R Friedländer; Sebastian D Mackowiak; Na Li; Wei Chen; Nikolaus Rajewsky Journal: Nucleic Acids Res Date: 2011-09-12 Impact factor: 16.971
Authors: Cristina Martínez; Bruno K Rodiño-Janeiro; Beatriz Lobo; Megan L Stanifer; Bernd Klaus; Martin Granzow; Ana M González-Castro; Eloisa Salvo-Romero; Carmen Alonso-Cotoner; Marc Pigrau; Ralph Roeth; Gudrun Rappold; Wolfgang Huber; Rosa González-Silos; Justo Lorenzo; Inés de Torres; Fernando Azpiroz; Steeve Boulant; María Vicario; Beate Niesler; Javier Santos Journal: Gut Date: 2017-01-12 Impact factor: 23.059
Authors: QiQi Zhou; Meghan L Verne; Jeremy Z Fields; John J Lefante; Sarpreet Basra; Habeeb Salameh; G Nicholas Verne Journal: Gut Date: 2018-08-14 Impact factor: 31.793